Research summary
Magnesium and Blood Pressure
Quick answer
Pooled data from randomized, double-blind, placebo-controlled trials suggest that oral magnesium supplementation at a median dose of about 368 mg/day for roughly 3 months is associated with small average reductions in systolic and diastolic blood pressure in adults. A second meta-analysis in adults with and without type 2 diabetes reported a comparable small reduction in systolic blood pressure. The effects are modest, the trials were short, and the authors of both analyses called for further well-designed studies, so magnesium should not be viewed as a stand-alone approach to managing blood pressure.[1], [2]
Limitations of the evidence
The blood-pressure effect of magnesium supplementation is modest and was measured over short study periods, with notable variation between trials. Findings come from supplementation studies in research settings and may not generalize to every individual; anyone considering magnesium for cardiovascular reasons should consult a qualified health professional.[1], [2]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In a meta-analysis of randomized, double-blind, placebo-controlled trials, oral magnesium supplementation at a median dose of about 368 mg/day for roughly 3 months was associated with a small average reduction in blood pressure (systolic by about 2 mm Hg and diastolic by about 1.8 mm Hg) in adults. Small average effect (about 2 mm Hg systolic and 1.8 mm Hg diastolic) at a median dose of about 368 mg/day over roughly 3 months; magnitude varied and authors noted residual heterogeneity. | [1], [2] |
| Across the pooled trials, an oral magnesium dose of about 300 mg/day or longer was the amount examined for raising serum magnesium and modestly lowering blood pressure in adults. Dose studied was approximately 300 to 368 mg/day of oral magnesium over about 1 to 3 months; this reflects amounts tested in the trials, not a recommended intake. | [1] |
| The pooled estimates carried meaningful statistical heterogeneity, and the authors called for further well-designed trials to confirm the blood-pressure effect of magnesium supplementation. Effect sizes were small with residual heterogeneity across trials; findings come from short-duration studies and are not a substitute for medical care. | [1], [2] |
What the evidence shows
A 2016 meta-analysis published in Hypertension pooled 34 randomized, double-blind, placebo-controlled trials involving 2,028 normotensive and hypertensive adults. Oral magnesium supplementation at a median dose of about 368 mg/day for a median of 3 months was associated with a small average reduction in blood pressure, lowering systolic blood pressure by roughly 2 mm Hg and diastolic blood pressure by roughly 1.8 mm Hg compared with placebo. These reductions were accompanied by a small rise in serum magnesium.[1], [2]
A separate 2017 systematic review and meta-analysis of randomized controlled trials, focused on cardiovascular risk factors in adults with and without type 2 diabetes, reported a comparable small reduction in systolic blood pressure of about 3 mm Hg with magnesium supplementation. This convergence across populations adds context, with a more pronounced effect noted in diabetic subjects who had low magnesium levels.[1], [2]
Doses studied
In the pooled trials, the amounts examined generally fell in the range of about 300 to 368 mg/day of oral magnesium taken over roughly 1 to 3 months. The authors observed that a dose of about 300 mg/day or a duration of about 1 month was sufficient to raise serum magnesium and produce a measurable change in blood pressure. These figures describe the amounts tested in research rather than a recommended intake, and individual needs differ.[1]
Limitations
The reported effects are small in absolute terms, and the pooled estimates carried meaningful statistical heterogeneity, meaning results varied across trials. Most studies were short, lasting only a few months, and the authors of both meta-analyses explicitly called for further well-designed trials before drawing firm conclusions. This information is educational and is not a substitute for individualized medical care.[1], [2]
References
- Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.. Hypertension (Dallas, Tex. : 1979). 2016. Systematic review and meta-analysis View source →
- Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2017. Systematic review and meta-analysis View source →
Frequently asked questions
Does magnesium support blood pressure and blood sugar?
Human evidence shows small, qualified signals. Randomized-trial meta-analyses reported modest average reductions in blood pressure and fasting plasma glucose, while prospective cohorts associated higher dietary magnesium intake with lower type 2 diabetes risk. The observational association does not prove causation, and the trial effects do not establish magnesium as a stand-alone treatment.
Sources: Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.; Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.; Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies.
Read the full FAQ and limitations →